Foster Dykema Cabot & Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.9K Hold
142
﹤0.01% 183
2025
Q4
$38.8K Hold
142
﹤0.01% 203
2025
Q3
$38.4K Hold
142
﹤0.01% 232
2025
Q2
$39.1K Hold
142
﹤0.01% 211
2025
Q1
$37.7K Hold
142
﹤0.01% 207
2024
Q4
$33.8K Hold
142
﹤0.01% 228
2024
Q3
$31.3K Hold
142
﹤0.01% 268
2024
Q2
$27.9K Hold
142
﹤0.01% 205
2024
Q1
$30.6K Hold
142
﹤0.01% 201
2023
Q4
$30.7K Buy
+142
New +$30.3K ﹤0.01% 173

Other funds holding CME

Foster Dykema Cabot & Partners's CME Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its CME Group (CME) position steady in Q1 2026 at 142 shares worth $41.9K. The position accounts for ﹤0.01% of the portfolio, ranked #183.

Foster Dykema Cabot & Partners first reported a position in CME in Q4 2023 and has held it in 10 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Foster Dykema Cabot & Partners held 142 shares of CME Group worth $41.9K as of Q1 2026.
  • Foster Dykema Cabot & Partners left its CME Group share count unchanged in Q1 2026.
  • CME Group made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #183 holding.
  • Foster Dykema Cabot & Partners first reported a position in CME Group in Q4 2023 and has held it in 10 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.